Austin, TX · Founded 2021 · Privately Held (backing)
Developer of a cancer treatment biotechnology designed to offer AAV-delivered T-cell Immunotherapy. Vironexis Biotherapeutics is based in Austin, TX and was founded in 2021. Its last reported valuation was $125 million in Feb 2025. It has raised $52 million.
Last reported valuation
$125.0M
Oct 2026
Priced at
—
Total raised
$52.0M
Last round
—
Team — not yet on record
No current team members for Vironexis Biotherapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vironexis Biotherapeutics with a free account
·Watch Vironexis Biotherapeutics: the Monday email on marks, rounds and moves
